Progression of LNCaP prostate tumor cells during androgen deprivation:: Hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest

被引:217
作者
Kokontis, JM
Hay, N
Liao, SS
机构
[1] Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Physiol & Pharmacol, Chicago, IL 60637 USA
[3] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA
关键词
D O I
10.1210/me.12.7.941
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The molecular mechanism of androgen-independent growth of prostate cancer after androgen ablation was explored in LNCaP cells. An androgen-dependent clonal subline of the LNCaP human prostate carcinoma cell line, LNCaP 104-S, progressed to a slow growing stage (104-R1) and then to a faster growing stage (104-R2) during more than 2 yr of continuous culture in the absence of androgen. Androgen-induced proliferation of 104-S cells is inhibited by the antiandrogen Casodex, while proliferation of 104-R1 and 104-R2 cells is unaffected by Casodex. This indicates that proliferation of 104-R1 and 104-R2 cells is not supported by low levels of androgen in the culture medium. Compared with LNCaP 104-S cells, both 104-R1 and 104-R2 cells express higher basal levels of androgen receptor (AR), and proliferation of these two cell lines is paradoxically repressed by androgen. After continuous passage in androgen-containing medium, 104-R1 cells reverted back to an androgen-dependent phenotype. The mechanism of androgenic repression of 104-R1 and 104-R2 sublines was further evaluated by examining the role of critical regulatory factors involved in the control of cell cycle progression. At concentrations that repressed growth, androgen transiently induced the expression of the cyclin-dependent kinase (cdk) inhibitor p21(waf1/cip1) in 104-R1 cells, while expression of the cdk inhibitor p27(Kip1) was persistently induced by androgen in both 104-R1 and 104-R2 cells. Induced expression of murine p27(Kip1) in 104-R2 cells resulted in G1 arrest. Specific immunoprecipitates of Cdk2 but not Cdk4 from androgen-treated 104-R1 cells contained both p21(waf1/cip1) and p27(Kip1). This observation was confirmed by in vitro assay of histone H1 and Rb (retinoblastoma protein) phosphorylation by the proteins associated with the immune complex. Furthermore, inhibition of Cdk2 activity correlated with the accumulation of p27(Kip1) and not p21(waf1/cip1). From these results we conclude that androgenic repression of LNCaP 104-R1 and 104-R2 cell proliferation is due to the induction of p27(Kip1) which in turn inhibits Cdk2, a factor critical for cell cycle progression and proliferation.
引用
收藏
页码:941 / 953
页数:13
相关论文
共 71 条
[21]   Translational control of p27(Kip1) accumulation during the cell cycle [J].
Hengst, L ;
Reed, SI .
SCIENCE, 1996, 271 (5257) :1861-1864
[22]  
HOBISCH A, 1995, CANCER RES, V55, P3068
[23]  
HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809
[24]  
HORWITZ KB, 1978, J BIOL CHEM, V253, P223
[25]   Studies on prostate cancer II The effects of castration on advanced carcinoma of the prostate gland [J].
Huggins, C ;
Stevens, RE ;
Hodges, CV .
ARCHIVES OF SURGERY, 1941, 43 (02) :209-223
[26]   Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model [J].
Hyytinen, ER ;
Thalmann, GN ;
Zhau, HE ;
Karhu, R ;
Kallioniemi, OP ;
Chung, LWK ;
Visakorpi, T .
BRITISH JOURNAL OF CANCER, 1997, 75 (02) :190-195
[27]   ESTABLISHMENT AND CHARACTERIZATION OF 7 DUNNING RAT PROSTATIC-CANCER CELL-LINES AND THEIR USE IN DEVELOPING METHODS FOR PREDICTING METASTATIC ABILITIES OF PROSTATIC CANCERS [J].
ISAACS, JT ;
ISAACS, WB ;
FEITZ, WFJ ;
SCHERES, J .
PROSTATE, 1986, 9 (03) :261-281
[28]  
ISAACS JT, 1981, CANCER RES, V41, P5070
[29]   ANDROGENS INHIBIT THE PROLIFERATION OF A VARIANT OF THE HUMAN PROSTATE-CANCER CELL-LINE LNCAP [J].
JOLYPHARABOZ, MO ;
SOAVE, MC ;
NICOLAS, B ;
MEBARKI, F ;
RENAUD, M ;
FOURY, O ;
MOREL, Y ;
ANDRE, JG .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 55 (01) :67-76
[30]  
KEMPPAINEN JA, 1992, J BIOL CHEM, V267, P968